Eu Ivdd Eu Ivd General On The Market 🇨🇳 China

First Sign®

Devices (same UDI-DI)
1
Certificates
0
Countries
0
Notified Bodies
0

Basic Information

Primary DI
D-WHATOCOVAg01U4
Basic UDI-DI Code
B-WHATOCOVAg01U4
Reference
WH-AT-OCOV010202
Device Types
Single use
Regulation
Eu Ivdd
Classification
Eu Ivd General
Status
On The Market

Additional Description

The First Sign® SARS-CoV-2 Antigen Test is a rapid lateral flow chromatographic immunoassay for the qualitative detection of SARS-CoV-2 antigens in nasopharyngeal swab (NP), anterior nasal swab (NS) and oropharyngeal swab (OS) specimens from individuals suspected of COVID-19 by their healthcare provider within the first seven days of symptom onset. An antigen is generally detectable in upper respiratory specimens during the acute phase of infection.

CND Nomenclature Codes

Code Description
W0105040619 CORONAVIRUS [obsolete from 2025-01-01]

Similar Devices

Other on-the-market devices with the same classification (Eu Ivd General) and regulation (EU IVDD).

View all